HP
HealthInvest Partners Portfolio holdings
AUM
$234M
This Quarter Return
+7.77%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$227M
AUM Growth
+$227M
(+7.4%)
Cap. Flow
+$2.8M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
59.15%
Holding
41
New
5
Increased
10
Reduced
19
Closed
4
Top Buys
| 1 |
Gilead Sciences
GILD
|
$8.63M |
| 2 |
Intuitive Surgical
ISRG
|
$7.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$3.88M |
| 4 |
Krystal Biotech
KRYS
|
$2.58M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$2.2M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$5.94M |
| 2 |
UnitedHealth
UNH
|
$4.93M |
| 3 |
Amicus Therapeutics
FOLD
|
$3.08M |
| 4 |
Boston Scientific
BSX
|
$2.21M |
| 5 |
Eli Lilly
LLY
|
$2.04M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $28.6M | 12.62% | 34,602 -2,466 | -7% | -$2.04M |
|
2
AbbVie
ABBV
$372B
| $18.7M | 8.25% | 89,227 -1,496 | -2% | -$313K |
|
|
3
UnitedHealth
UNH
$281B
| $13.5M | 5.96% | 25,782 -9,420 | -27% | -$4.93M |
|
|
4
Boston Scientific
BSX
$156B
| $13.3M | 5.89% | 132,273 -21,949 | -14% | -$2.21M |
|
5
Merck
MRK
$210B
| $11.5M | 5.06% | 127,679 +21,952 | +21% | +$1.97M |
|
6
Thermo Fisher Scientific
TMO
$186B
| $11.4M | 5.02% | 22,857 -2,039 | -8% | -$1.01M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $11.1M | 4.88% | 22,808 +551 | +2% | +$267K |
|
8
Cencora
COR
$56.5B
| $8.77M | 3.87% | 31,553 -1,000 | -3% | -$278K |
|
|
9
Gilead Sciences
GILD
$140B
| $8.63M | 3.81% | +76,998 | New | +$8.63M |
|
10
Stryker
SYK
$150B
| $8.56M | 3.78% | 22,998 -2,662 | -10% | -$991K |
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $8.39M | 3.71% | 75,881 +8,118 | +12% | +$898K |
|
12
Amgen
AMGN
$155B
| $8.28M | 3.66% | 26,577 -837 | -3% | -$261K |
|
|
13
Intuitive Surgical
ISRG
$170B
| $7.6M | 3.36% | +15,345 | New | +$7.6M |
|
14
Alkermes
ALKS
$4.78B
| $7.09M | 3.13% | 214,778 -51,721 | -19% | -$1.71M |
|
|
ONC
15
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $6.84M | 3.02% | 25,141 +14,241 | +131% | +$3.88M |
|
16
BridgeBio Pharma
BBIO
$9.89B
| $5.23M | 2.31% | 151,348 +48,316 | +47% | +$1.67M |
|
17
Edwards Lifesciences
EW
$47.8B
| $4.33M | 1.91% | 59,696 -8,600 | -13% | -$623K |
|
18
UFP Technologies
UFPT
$1.62B
| $4.29M | 1.89% | 21,259 -1,900 | -8% | -$383K |
|
|
19
Krystal Biotech
KRYS
$4.27B
| $4.24M | 1.87% | 23,491 +14,289 | +155% | +$2.58M |
|
20
Cardinal Health
CAH
$35.5B
| $3.81M | 1.68% | 27,688 -2,992 | -10% | -$412K |
|
21
Mirum Pharmaceuticals
MIRM
$3.71B
| $3.48M | 1.54% | 77,263 -39,429 | -34% | -$1.78M |
|
22
DexCom
DXCM
$29.5B
| $3.13M | 1.38% | 45,841 -14,216 | -24% | -$971K |
|
23
Harmony Biosciences
HRMY
$2.12B
| $3.03M | 1.34% | 91,301 -29,200 | -24% | -$969K |
|
24
Arcellx
ACLX
$3.85B
| $2.9M | 1.28% | 44,171 +2,100 | +5% | +$138K |
|
25
Soleno Therapeutics
SLNO
$3.6B
| $2.65M | 1.17% | 37,098 +6,158 | +20% | +$440K |
|